1.      Bräunig P, Krüger S, Shugar G. Prevalence and clinical significance of catatonic symptoms in mania. Compr Psychiatry. 1998;39(1):35-46.

2.      Bush G, Fink M, Petrides G, et al. Catatonia: II: treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996;93:137-143.

3.      Cohen D. Towards a valid nosography and psychopathology of catatonia in children and adolescents. Int Rev Neurobiol. 2006;72:131-147.

4.      Davis JM, Caroff SN, Mann SC. Treatment of neuroleptic malignant syndrome. Psychiatr Ann. 2000;30:325-331.

5.      Dickson LR. Hypoalbuminemia in delirium. Psychosomatics. 1991;32:317–323.

6.      Fink M, Taylor MA. Catatonia: A Clinician's Guide to Diagnosis and Treatment. Cambridge, UK: Cambridge University Press; 2006.

7.      Fink M, Taylor MA. The many varieties of catatonia. Eur Arch Psychiatry Clin Neurosci. 2001;251(Suppl 1):8-13.

8.      Grover S, Kate N, Malhotra S, et al. Symptom profile of delirium in children and adolescent—does it differ from adults and elderly? Gen Hosp Psychiatry. 2012;34(6):626-632.

9.      Hatherill S, Flisher AJ. Delirium in children and adolescents: a systematic review of the literature. J Psychosom Res. 2010;68(4):337-344.

10.  Inouye SK, Bogardus ST Jr, Charpentier PA, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med. 1999;340:669–676.

11.  Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly patients: predictive model and interrelationships with baseline vulnerability. JAMA. 1996;275:852–857.

12.  Johnson JC, Kerse NM, Gottlieb G, et al. Prospective versus retrospective methods of identifying patients with delirium. J Am Geriatr Soc. 1992;40:316–319.

13.  Kruger S, Braunig P. Catatonia in affective disorder: new findings and a review of the literature. CNS Spectrums. 2000;5:48–53.

14.  Leentjens AF, Schieveld JN, Leonard M, et al. A comparison of the phenomenology of pediatric, adult, and geriatric delirium. J Psychosom Res. 2008;64(2):219-223.

15.  Meagher DJ, O’Hanlon D, O’Mahony E, et al. Use of environmental strategies and psychotropic medication in the management of delirium. Br J Psychiatry. 1996;168:512–515.

16.  Menza MA, Murray GB, Holmes VF, et al. Decreased extrapyramidal symptoms with intravenous haloperidol. J Clin Psychiatry. 1987;48:278–280.

17.  Montgomery EA, Fenton GW, McClelland RJ, et al. Psychobiology of minor head injury. Psychosom Med. 1991;21:375–384.

18.  O’Keefe S, Lavan J. The prognostic significance of delirium in older hospital patients. J Am Geriatr Soc. 1997;45:174–178.

19.  O’Keeffe ST, Lavan J. Clinical significance of delirium subtypes in older people. Age Ageing. 1999;28:115–119.

20.  Schieveld JN, Leentjens AF. Delirium in severely ill young children in the pediatric intensive care unit. J Am Acad Child Adolesc Psychiatry. 2005;44:392-394.

21.  Seear M, Lockitch G, Jacobson B, et al. Thiamine, riboflavin and pyridoxine deficiency in a population of critically ill children. J Pediatr. 1992;121:533–538.

22.  Slooter AJ, Balk FJ, van Nieuwenhuizen O, et al. Electroconvulsive therapy for malignant catatonia in childhood. Pediatr Neurol. 2005;32:190–192.

23.  Smith HA, Brink E, Fuchs DC, et al. Pediatric delirium: monitoring and management in the pediatric intensive care unit. Pediatr Clin North Am. 2013;60(3):741-760.

24.  Thakur A, Jagadheesan K, Dutta S, et al. Incidence of catatonia in children and adolescents in a paediatric psychiatric clinic. Aust N Z J Psychiatry. 2003;37:200-203.

25.  Trzepacz PT, Meagher DF, Wise M. Neuropsychiatric aspects of delirium. In: Yudofsky SC, Hales RE, eds. The American Psychiatric Publishing Textbook of Neuropsychiatry and Clinical Neurosciences. 4th ed. Washington, DC: American Psychiatric Publishing; 2002:525–564.

26.  Trzepacz PT. A review of delirium assessment instruments. Gen Hosp Psychiatry. 1994;16:394-405.

27.  Trzepacz PT. Update on the neuropathogenesis of delirium. Dement Geriatr Cogn Disord. 1999;10:330–334.

28.  Turkel SB, Tavare CJ. Delirium in children and adolescents. J Neuropsychiatry Clin Neurosci. 2003;15:431–435.

29.  Ungvari GS, Chiu HFK, Chow LY, et al. Lorazepam for chronic catatonia: a randomized, double-blind, placebo-controlled crossover study. Psychopharmacology. 1999;142:393–398.

30.  Ungvari GS, Kau LS, Wai-Kwong T, et al. The pharmacological treatment of catatonia: an overview. Eur Arch Psychiatry Clin Neurosci. 2001;251(Suppl 1):31–34.

31.  Williams DT. Somatoform disorders. In: Rowland LP, ed. Merritt’s Neurology. 11th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:1140–1145.

32.  Wing L, Shah A. Catatonia in autistic spectrum disorders. Br J Psychiatry. 2000;176(4):357-362.

33.  Wise MG, Hilty DM, Cerda GM. Delirium due to a general medical condition, delirium due to multiple etiologies, and delirium not otherwise specified. In: Gabbard GO, ed. Treatment of Psychiatric Disorders. 3rd ed. Washington, DC: American Psychiatric Publishing; 2001:387–412.